Doing the Good Work: SM underscores practical sustainability at industry forum

by | PRNewswire Asia

PASAY CITY, Philippines, Oct. 22, 2025 /PRNewswire/ — SM Investments Corporation (SM Investments), the parent company of the SM group, emphasized its practical approach to sustainability at The Dirty Work of Doing Good, a sustainability conference organized...

HMI Medical Expands Advanced Imaging Services to Strengthen Diagnostic Capabilities in Singapore

by | PRNewswire Asia

HMI Radiology (Novena) will deliver a full suite of diagnostic imaging services to aid in early detection and proactive health management in the community Integration of Siemens Healthineers high-resolution imaging systems and AI-enhanced workflows drives...

Across Mountains and Seas, A Shared Delicacy – Xinjiang Nileke Salmon Food Festival Lights Up the Night at Marina Bay Sands Singapore

by | PRNewswire Asia

Tianshan Salmon Leaps onto the International Stage, Tianyun Quality Illuminates a New Chapter in China-Singapore Culinary Exchange SINGAPORE, Oct. 22, 2025 /PRNewswire/ — Amidst the glittering lights of Singapore, the "Convergence of Flavours, Meet at...

SUS Leads Thailand's Waste-to-Energy Market with Integrated Tech, Manufacturing, and Service Model

by | PRNewswire Asia

SHANGHAI, Oct. 22, 2025 /PRNewswire/ — Amid the global push to address climate change, Waste-to-Energy (WtE) has emerged as a critical solution for Thailand’s dual challenges of energy transition and urban waste management. In line with the...

LISCure BioSciences Secures World's First Approval for "Joint Health Probiotic" as Recognized Health Functional Ingredient

by | PRNewswire Asia

SEOUL, South Korea, Oct. 22, 2025 /PRNewswire/ — LISCure BioSciences ("LISCure") announced that its proprietary joint health probiotic, JointWorks®, has been officially approved by the Korean Ministry of Food and Drug Safety (MFDS) as Recognized...

Renalys Pharma Announces Support for Alport Syndrome Registry Study Organized by Japanese Society for Pediatric Nephrology

by | PRNewswire Asia

TOKYO, Oct. 22, 2025 /PRNewswire/ — Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; "Renalys") is pleased to announce the company is providing financial support for the Alport Syndrome Registry Study organized by the Japanese Society for Pediatric...